Main Management ETF Advisors, LLC Krystal Biotech, Inc. Transaction History
Main Management ETF Advisors, LLC
- $2.21 Billion
- Q4 2024
A detailed history of Main Management ETF Advisors, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 3,560 shares of KRYS stock, worth $671,451. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,560
Previous 3,880
8.25%
Holding current value
$671,451
Previous $706,000
20.96%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$745 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$543 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$496 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$241 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$166 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.84B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...